Treatment of infections caused by multi-resistant microorganisms in hospital at home units.

Hospital at home units allow the treatment of moderate and severe infections by administering intravenous antibiotics to patients who would otherwise have to remain hospitalised. Increasing antibiotic resistance adds an element of difficulty to outpatient treatment of infections because multiple daily doses of antimicrobials or combinations of antimicrobials are sometimes required. This manuscript discusses some of the challenges of outpatient management of infections with multidrug- resistant microorganisms and shows the main antibiotic resistances and the outcomes of treatment of these infections in Spanish home hospitalisation units.post-print107 K

Las crisis, las oportunidades… y la hospitalización a domicilio

Todas las crisis, con independencia de su naturaleza e intensidad, ocasionan víctimas y secuelas. Cuando esas crisis se producen en el terreno de la salud, los afectados sufren enfermedades y, en casos extremos, la muerte. La pandemia por coronavirus es un claro ejemplo de cómo las crisis sanitarias representan una amenaza real para nuestra salud y para nuestras vidas

Telemonitoring and home hospitalization in patients with chronic obstructive pulmonary disease: study TELEPOC.

Background: Chronic obstructive pulmonary disease (COPD) is a major consumer of healthcare resources, with most costs related to disease exacerbations. Telemonitoring of patients with COPD may help to reduce the number of exacerbations and/or the related costs. On the other hand, home hospitalization is a cost-saving alternative to inpatient hospitalization associated with increased comfort 15 for patients. The results are reported regarding using telemonitoring and home hospitalization for the management of patients with COPD. Methods: Twenty-eight patients monitored their health parameters at home for six months. A nurse remotely revised the collected parameters and followed the patients as programmed. A home care unit was dispatched to the patients’ home if an alarm signal was detected. The outcomes were compared to 20 historical data from the same patients. Results: The number of COPD exacerbations during the study period did not reduce but the number of hospital admissions decreased by 60% and the number of emergency room visits by 38%. On average, costs related to utilization of healthcare resources were reduced by €1,860.80 per patient per year. Conclusions: Telemonitoring of patients with COPD combined with home hospitalization may allow for AQ425 a reduction in healthcare costs, although its usefulness in preventing exacerbations is still unclearpre-print664 K

Proyecto HAD 2020: una propuesta para consolidar la hospitalización a domicilio en España

Hospital at home (HAH) appeared in Spain 36 years ago with the opening of several units. The initial push was truncated by the lack of political leadership and sometimes clinical as well. The current reality offers an irregular implementation with a wide disparity of assistance and resource models. The Sociedad Española de Hospitalización a Domicilio (SEHAD) has not played either the expected scientific or professional leadership roles. The “Plan HAD2020: key of the future” was designed as revulsive. This is an ambitious 4-year project to consolidate HAH as a care modality. Its deployment consists of five phases. Preparation: the foundations of the strategic plan (EP) were established. Situation analysis: a national survey was carried out on the 106 operational units (data 2014). Validation of the EP: contributions and proposals of action of the members of SEHAD. National Congress 2016: presentation and approval of EP conclusions and proposals. EP deployment phase: it will be extended until 2020 and will be executed by various teams of referents spread over five lines of work.The final objective set for the year 2020 is: to come up with a more homogenous care model; to promote the training and professional recognition of those who work in the HAD; that each hospital in Spain has a HAH unit; recognition and empowerment by the national health system.HAD2020 has marked an inflection point in the SEHAD. The traced path and the effort of all the HAH professionals will allow reaching the vision which the pioneers of the HAH in Spain pursued.La Hospitalización a Domicilio (HAD) apareció en España hace 36 años con la apertura de diversas unidades. El empuje inicial fue truncado por la falta de liderazgo político y en ocasiones también clínico. La realidad actual ofrece una implantación irregular con disparidad de modelos asistenciales y de recursos. La Sociedad Española de Hospitalización a Domicilio (SEHAD) no ha jugado el papel de liderazgo científico y profesional esperado. Se diseñó el «Plan HAD2020: clave de futuro» como revulsivo. Se trata de un ambicioso proyecto a 4 años para consolidar la HAD como modalidad asistencial. Su despliegue consta de cinco fases. Preparación: se establecieron las bases del plan estratégico (PE). Análisis de situación: se realizó una encuesta nacional a las 106 unidades operativas (datos 2014). Validación del PE: aportaciones y propuestas de actuación de los miembros de SEHAD. Congreso Nacional 2016: presentación y aprobación de conclusiones y propuestas del PE. Fase de despliegue PE: se extenderá hasta el año 2020 y la ejecutarán diversos equipos referentes, repartidos en cinco líneas de trabajo.El objetivo final fijado para el año 2020 consiste en: consensuar un modelo asistencial más homogéneo; promover la formación y reconocimiento profesional de quienes trabajan en la HAD; que cada hospital de España tenga una unidad de HAD; reconocimiento y potenciación por el sistema de salud nacional.HAD2020 ha marcado un punto de inflexión en la SEHAD. El camino trazado y el esfuerzo de todos los profesionales HAD permitirán alcanzar aquella visión que persiguieron los pioneros de la HAD en España

Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

Community-acquired pneumonia represents the third-highest cause of mortality in industrialized countries and the first due to infection. Although guidelines for the approach to this infection model are widely implemented in international health schemes, information continually emerges that generates controversy or requires updating its management. This paper reviews the most important issues in the approach to this process, such as an aetiologic update using new molecular platforms or imaging techniques, including the diagnostic stewardship in different clinical settings. It also reviews both the Intensive Care Unit admission criteria and those of clinical stability to discharge. An update in antibiotic, in oxygen, or steroidal therapy is presented. It also analyzes the management out-of-hospital in CAP requiring hospitalization, the main factors for readmission, and an approach to therapeutic failure or rescue. Finally, the main strategies for prevention and vaccination in both immunocompetent and immunocompromised hosts are reviewed

Resumen Ejecutivo del tratamiento antibiótico domiciliario endovenoso: Directrices de la Sociedad Española de Enfermedades Infecciosas y la Sociedad Española de Hospitalización a Domicilio

Outpatient parenteral antimicrobial therapy (OPAT) programmes make it possible to start or complete intravenous antimicrobial therapy for practically any type of infection at home, provided that patient selection is appropriate for the type of OPAT programme available. Although the clinical management of infections in the home setting is comparable in many respects to that offered in conventional hospitalization (selection of antibiotics, duration of treatment, etc.), there are many aspects that are specific to this care modality. It is essential to be aware of them so that OPAT continues to be as safe and effective as inpatient care. The objective of this clinical guideline is therefore to provide evidence-and expert-based recommendations with a view to standardizing clinical practice in this care modality and contribute to a progressive increase in the number of patients who can be cared for and receive intravenous therapy in their own homes.Los programas de tratamiento antibiótico domiciliario endovenoso (TADE) permiten iniciar o completar el tratamiento antimicrobiano por vía endovenosa de prácticamente cualquier tipo de infección en el domicilio, siempre y cuando se realice una selección del paciente acorde al tipo de programa de TADE que se dispone. Aunque hay aspectos del manejo clínico de las infecciones en el domicilio que son superponibles en la mayoría de los casos a la realizada en la hospitalización convencional (selección de la antibioterapia, duración del tratamiento, etc.), existen numerosos aspectos que son específicos de esta modalidad asistencial. Resulta imprescindible conocerlos para que el TADE siga siendo igual de eficaz y seguro que la hospitalización convencional. El objetivo de esta guía clínica es por tanto proporcionar recomendaciones basadas en la evidencia realizadas por expertos para homogeneizar la práctica clínica de esta modalidad asistencial y contribuir a que se incremente progresivamente el número de pacientes que pueden ser atendidos y recibir tratamiento endovenoso en su propio domicilio